Literature DB >> 16830816

[Review of bioactivities of natural cycloartane triterpenoids].

Ze Tian1, Pei-gen Xiao, Jie Wen, Feng Huang, Meng-su Yang, Shi-lin Chen.   

Abstract

Cycloartane triterpenoids, which exist widely in nature, are mainly distributed in Astragalus (Leguminosae) species, Trib. Cimicifuga (Ranunculaceae) and Thalictrium (Ranunculaceae) species and possess various bioactivities. Along with the development of isolation techniques of phytochemistry, more and more this kind of compounds are isolated and identified. However, bioactivity researches on the compounds are relatively lagged behind. Most researches are still in screening level, deficient in mechanism elucidation, short of action proven in vivo and SAR analysis. The author summarized the bioactivity of this kind of compounds from all aspects: anti-tumor, anti-virus, antibacterial, anti-inflammation, immune-regulatory, cardiovascular system, hepatic protection and so forth. This will be benefit for the further research and development of the compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830816

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Anti-convulsant effect and mechanism of Astragalus mongholicus extract in vitro and in vivo: protection against oxidative damage and mitochondrial dysfunction.

Authors:  Jalsrai Aldarmaa; Zhongbo Liu; Jiangang Long; Xiaoyan Mo; Jiangang Ma; Jiankang Liu
Journal:  Neurochem Res       Date:  2009-07-04       Impact factor: 3.996

Review 2.  Anticancer Chemodiversity of Ranunculaceae Medicinal Plants: Molecular Mechanisms and Functions.

Authors:  Da-Cheng Hao; Chun-Nian He; Jie Shen; Pei-Gen Xiao
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

3.  Cycloartanes from Oxyanthus pallidus and derivatives with analgesic activities.

Authors:  Basile Nganmegne Piegang; Ignas Bertrand Nzedong Tigoufack; David Ngnokam; Angèle Sorel Achounna; Pierre Watcho; Wolfgang Greffrath; Rolf-Detlef Treede; Télesphore Benoît Nguelefack
Journal:  BMC Complement Altern Med       Date:  2016-03-09       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.